Home/Pipeline/TeaRx™

TeaRx™

Dry eye and ocular surface disease diagnosis

Pre‑clinical/early clinicalActive

Key Facts

Indication
Dry eye and ocular surface disease diagnosis
Phase
Pre‑clinical/early clinical
Status
Active
Company

About BioLight

Israel's sole publicly listed ophthalmology‑focused investment platform, BioLight builds a diversified portfolio of innovative eye‑care technologies.

View full company profile

Therapeutic Areas